Anlotinib Plus Whole-Brain Radiotherapy for Brain Metastases in SCLC Patients.
Clinical trial NCT07443397 · RECRUITING
Trial details
- NCT number
- NCT07443397
- Sponsor
- Cancer Institute and Hospital, Chinese Academy of Medical Sciences
- Status
- RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2025-08-29
- Primary completion
- 2027-08-31
- Enrollment
- 134
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.